Publications

Publications 2011

December 31, 2011
  1. Soliman EZ, Lundgren JD, Roediger MP, Duprez DA, Temesgen Z, BIockel M, Shlay JC, Somboonwit C, Reiss P, Stein JH, Neaton JD for the INSIGHT SMART Study Group. Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS. 2011 Jan 28;25(3):367-77. doi: 10.1097/QAD.0b013e328341dcc0.
  2. Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD for the INSIGHT SMART study group. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):36-43. doi: 10.1097/QAI.0b013e3181f7f61a.
  3. Smith W, Grady C, Krohmal B, Lazovski J, Wendler D for INSIGHT ESPRIT Group (S Emery – Executive Committee member). Empirical evaluation of the need for ‘on-going consent’ in clinical research. AIDS. 2011 Jan 2;25(1):107-14. doi: 10.1097/QAD.0b013e328340fec7.
  4. Iser DM, Avihingsanon A, Thompson AJ, Wisedopas N, Boyd A, Matthews GV, Locarnini SA, Slavin J, Desmond PV, Lewin SR. Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression. AIDS. 2011 Jan 14;25(2):197-205. doi: 10.1097/QAD.0b013e3283410ccb.
  5. Bunupuradah T, Kosalaraksa P, Puthanakit T, Mengthaisong T, Wongsabut J, Lumbiganon P, Phanuphak P, Burger D, Pancharoen C, Ananworanich J; HIV-NAT 077 Study Team. Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children. AIDS. 2011 Jan 28;25(3):315-23. doi: 10.1097/QAD.0b013e32834231f5.
  6. TREAT Asia Pediatric HIV Observational Database (TApHOD); International Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric Group. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc. 2011 Feb 9;14:7. doi: 10.1186/1758-2652-14-7.
  7. Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon P, Hansudewechakul R, Amin J, Kumarasamy N, Puthanakit T, Kurniati N, Nik Yusoff NK, Saphonn V, Fong SM, Razali K, Nallusamy R, Sohn AH, Sirisanthana V. Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol. 2011 Feb;40(1):15-24. doi: 10.1093/ije/dyp358. Epub 2010 Jan 25.
  8. Ananworanich J, Kerr SJ, Vernazza P, Mangclaviraj S, Chaithongwongwatthana S, Chotnopparatpattara P, Mahanontharit A, Ubolyam S, Jupimai T, Cooper DA, Ruxrungtham K, Hirschel B and the Staccato HIV-NAT Study Group. Genital shedding of HIV after scheduled treatment interruption. Int J STD AIDS. 2011 Feb;22(2):61-6. doi: 10.1258/ijsa.2010.009594.
  9. Phanuphak N, Pattanachaiwit S, Pankam T, Pima W, Avihingsanon A, Teeratakulpisarn N. Active voluntary counseling and testing with integrated CD4 count service can enhance early HIV testing and linkage to HIV care: experiences from the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):244-52. doi: 10.1097/QAI.0b013e318207597f.
  10. Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD for the INSIGHT SMART Group. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. AIDS. 2011 Mar 13;25(5):651-7. doi: 10.1097/QAD.0b013e32834404a1.
  11. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, Neaton JD, Brenchley JM, Deeks SG, Sereti I, Douek DC; INSIGHT SMART Study Group. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011 Mar 15;203(6):780-90. doi: 10.1093/infdis/jiq118. Epub 2011 Jan 20.
  12. PENPACT-1 (PENTA 9/PACTG 390) Study Team, Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.
  13. Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7. doi: 10.1093/cid/cir107.
  14. Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHTESPRIT Study Group. Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.
  15. Bunupuradah T, Ananworanich J, Pancharoen C, Petoumenos K, Prasitsuebsai W, Wongngam W , Ubolyam S, Sriheara C, Lange J, Phanuphak P, Puthanakit T. Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression. Vaccine. 2011 Apr 5;29(16):2962-7. doi: 10.1016/j.vaccine.2011.01.114. Epub 2011 Feb 15.
  16. Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, Kumarasamy N, Chokephaibulkit K, Nik Yusoff NK, Vonthanak S, Moy FS, Razali KA, Nallusamy R, Sohn AH; TREAT Asia Pediatric HIV Observational Database (TApHOD). Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011 Apr;56(4):365-71. doi: 10.1097/QAI.0b013e318207a55b.
  17. Taweesith W, Puthanakit T, Kowitdamrong E, Bunupuradah T, Wongngam W, Phasomsap C, Apornpong T, Bouko C, Pancharoen C. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in Human Immunodeficiency Virus-infected children. Pediatr Infect Dis J. 2011 Apr;30(4):320-4. doi: 10.1097/INF.0b013e3181fe0868.
  18. Clarke A, Ramautarsing R, Ohata PJ, Hsu D, Landolt NK, Kerr SJ, Avihingsanon A, Maek-anantawat W, Puthanakit T, Bunupuradah T, Prasitsuebsai W, Ananworanich J, Ruxrungtham K. The 14th Bangkok International Symposium on HIV Medicine. Future Virology. 2011 Apr;6(4):409-412.
  19. Achhra AC, Zhou J, Choi JY, Hoy J, Zhang F, Templeton DJ, Merati T, Woolley I, Petoumenos K, Amin J and and TAHOD and AHOD. The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD. J Int Assoc Physicians AIDS Care (Chic). 2011 May-Jun;10(3):160-70. doi: 10.1177/1545109711402213. Epub 2011 Apr 20.
  20. Kancheva Landolt NT, Lakhonphon S and Ananworanich J. Contraception in HIV-positive female adolescents. AIDS Res Ther. 2011 Jun 1;8(1):19. doi: 10.1186/1742-6405-8-19.
  21. Schneider K, Puthanakit T, Ohata J, Kerr S, Law MG, Cooper DA, Donovan B, Phanuphak N, Sirisanthana V, Ananworanich J, Wilson DP. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. AIDS. 2011 Jun 1;25(9):1143-51. doi: 10.1097/QAD.0b013e3283466fab.
  22. Ramautarsing RA, van der Lugt J, Gorowara M, Kerr SJ, Burger D, Ruxrungtham K, Phanuphak P, Chaithongwongwatthana S, Avihingsanon A, Phanuphak N. Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy. AIDS. 2011 Jun 19;25(10):1299-303. doi: 10.1097/QAD.0b013e328347f7e9.
  23. Dwyer DE, The INSIGHT Influenza Study Group. Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: The INSIGHT FLU 002 and FLU 003 studies. Vaccine. 2011 Jul 22;29 Suppl 2:B56-62. doi: 10.1016/j.vaccine.2011.04.105.
  24. Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T. The Immunogenicity and Safety of Pneumococcal Conjugate Vaccine in Human munodeficiency Virus-Infected Thai Children Vaccine. Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3.
  25. Edwards-Jackson N, Kerr SJ, Tieu HV, Ananworanich J, Hammer SM, Ruxrungtham K, Phanuphak P, Avihingsanon A. Cardiovascular Risk Assessment in Persons with HIV in the Developing World: Comparing Three Risk Equations in a Cohort of HIV-infected Thais. HIV Med. 2011 Sep;12(8):510-5. doi: 10.1111/j.1468-1293.2011.00916.x. Epub 2011 Mar 6.
  26. Bunupuradah T, Puthanakit T, Kosalaraksa P, Kerr S, Boonrak P, Prasitsuebsai W, Lumbiganon P, Mengthaisong T, Phasomsap C, Pancharoen C, Ruxrungtham K, Ananworanich J and the Pediatric Study Team. Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children. AIDS Res Ther. 2011 Oct 26;8:40. doi: 10.1186/1742-6405-8-40.
  27. Bunupuradah T, Ananworanich J, Chetchotisakd P, Kantipong P, Jirajariyavet S, Sirivichayakul S, Munsakul W, Prasithsirikul W , Sungkanuparph S, Bowonwattanuwong C, Klinbuayaem V, Petoumenos K, Hirschel B, Bhakeecheep S, Ruxrungtham K. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens. Antivir Ther. 2011;16(7):1113-21. doi: 10.3851/IMP1906.
  28. Audsley J, Seaberg EC, Sasadeusz J, Matthews GV, Avihingsanon A, Ruxrungtham K, Fairley K, Finlayson R, Hwang HS, Littlejohn M, Locarnini S, Dore GJ, Thio CL, and Lewin SR. Factors associated with elevated ALT in an international HIV/ HBV co-infected cohort on long-term HAART. PLoS One. 2011;6(11):e26482. doi: 10.1371/journal.pone.0026482. Epub 2011 Nov 1.
  29. Mocroft A, Lifson AR, Touloumi G, Neuhaus J, Fox Z, Palfreeman A, Vjecha MJ, Hodder S, De Wit S, Lundgren JD, Phillips AN for the INSIGHT SMART Study Group. Haemoglobin and anaemia in the SMART study. Antivir Ther. 2011;16(3):329-37. doi: 10.3851/IMP1746.
  30. Kanjanavanit S, Puthanakit T, Vibol U, Kosalaraksa P, Hansudewechakul R , Ngampiyasakul C, Wongsawat J, Luesomboon W, Wongsabut J, Mahanontharit A, Suwanlerk T, Saphonn V Ananworanich J Ruxrungtham K and on behalf of the PREDICT study group. High prevalence of lipid abnormalities among Antiretroviralnaïve HIV-infected Asian children with mild to moderate immunosuppression. Antivir Ther. 2011;16(8):1351-5. doi: 10.3851/IMP1897.
  31. Han SH, Zhou J, Saghayam S, Vanar S, Phanuphak N, Chen YM, Sirisanthana T, Sungkanuparph S, Lee CK, Pujari S, Li PC,Oka S, Saphonn V, Zhang F, Merati TP, Law MG, Choi JY. Prevalence of and risk factors for lipodystrophy among HIVinfected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD). Endocr J. 2011;58(6):475-84. Epub 2011 Apr 27.